Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Dirk RadesMarkus Moehler

Abstract

To investigate the efficacy and toxicity of cetuximab when added to radiochemotherapy for unresectable esophageal cancer. This randomized phase 2 trial (clinicaltrials.gov, identifier NCT01787006) compared radiochemotherapy plus cetuximab (arm A) to radiochemotherapy (arm B) for unresectable esophageal cancer. Primary objective was 2‑year overall survival (OS). Arm A was considered insufficiently active if 2‑year OS was ≤40% (null hypothesis = H0), and promising if the lower limit of the 95% confidence interval was >45%. If that lower limit was >40%, H0 was rejected. Secondary objectives included progression-free survival (PFS), locoregional control (LC), metastases-free survival (MFS), response, and toxicity. The study was terminated early after 74 patients; 68 patients were evaluable. Two-year OS was 71% in arm A (95% CI: 55-87%) vs. 53% in arm B (95% CI: 36-71%); H0 was rejected. Median OS was 49.1 vs. 24.1 months (p = 0.147). Hazard ratio (HR) for death was 0.60 (95% CI: 0.30-1.21). At 2 years, PFS was 56% vs. 44%, LC 84% vs. 72%, and MFS 74% vs. 54%. HRs were 0.51 (0.25-1.04) for progression, 0.43 (0.13-1.40) for locoregional failure, and 0.43 (0.17-1.05) for distant metastasis. Overall response was 81% vs. 69% (p = 0.262)...Continue Reading

Associated Clinical Trials

References

Mar 11, 1999·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·T HiraiT Toge
Jun 13, 2000·Cancer Biotherapy & Radiopharmaceuticals·M N SalehD J Buchsbaum
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Udo VanhoeferJosé Baselga
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Kenneth A FoonGisela M Schwab
Apr 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael StahlHansjochen Wilke
Apr 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurent BedenneChristine Binquet
Nov 6, 2007·International Journal of Radiation Oncology, Biology, Physics·Howard SafranTeresa Kennedy
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Feb 6, 2010·International Journal of Radiation Oncology, Biology, Physics·Megan Dann FesinmeyerScott D Ramsey
Mar 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Lawrence B MarksJoseph O Deasy
Jan 6, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas RuhstallerViviane Hess
Apr 7, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Michael B TomblynUNKNOWN SWOG GI Committee
Jun 1, 2012·The New England Journal of Medicine·P van HagenUNKNOWN CROSS Group
Aug 27, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Kian AngRita S Axelrod
Feb 5, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gérard LledoAimery de Gramont
Sep 17, 2017·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Matthias Felix HaefnerFlorian Sterzing
Jan 20, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Nina-Sophie HegemannFalk Roeder
Apr 11, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T RuhstallerUNKNOWN Swiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian ‘Arbeitsgemeinschaft
Jun 7, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Stephanie VitzGerhard G Grabenbauer
Oct 27, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Marcel NachbarCihan Gani
Jan 9, 2020·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy test
contraception

Clinical Trials Mentioned

NCT01787006

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Frontiers of Radiation Therapy and Oncology
Stefan HöchtWolfgang Hinkelbein
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Dirk RadesSteven E Schild
Annali italiani di chirurgia
P Bidoli, P M Salvini
Annals of Oncology : Official Journal of the European Society for Medical Oncology
T RuhstallerSwiss Group for Clinical Cancer Research (SAKK), the German Esophageal Cancer Study Group, the Austrian ‘Arbeitsgemeinschaft
© 2022 Meta ULC. All rights reserved